Predictive factors that influence the course of medullary thyroid carcinoma

被引:27
|
作者
Pazaitou-Panayiotou, Kalliopi [1 ]
Chrisoulidou, Alexandra [1 ]
Mandanas, Stylianos [1 ]
Tziomalos, Konstantinos [1 ]
Doumala, Eleni [1 ]
Patakiouta, Frideriki [2 ]
机构
[1] Theagenio Canc Hosp, Dept Endocrinol & Endocrine Oncol, Thessaloniki 54007, Greece
[2] Theagenio Canc Hosp, Dept Pathol, Thessaloniki 54007, Greece
关键词
Thyroid; Medullary cancer; Metastases; Predictive factors; PROGNOSTIC-FACTORS; ROUTINE MEASUREMENT; SERUM CALCITONIN; CANCER; EXPERIENCE; DIAGNOSIS; MICROCARCINOMA; DISORDERS;
D O I
10.1007/s10147-013-0588-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Medullary thyroid cancer (MTC) is an infrequent form of thyroid cancer. We aimed to examine how gender and histological characteristics influence the rate of recurrence/persistent disease, distant metastases and survival and also to define specific characteristics of MTC microcarcinomas. The medical records of 85 patients with MTC were reviewed. The following characteristics were recorded: year of diagnosis, age at diagnosis, sex, tumor size, number of tumor foci, lymph node metastases, thyroid capsule and vascular invasion, infiltration of thyroid parenchyma and extrathyroid extension, and distant metastases. During follow-up (mean 78.8 months), persistent disease occurred in 40 patients, local recurrences in 5 and distant metastases in 32 patients. Local and distant disease appeared more frequently in patients with larger tumors (p < 0.005) and lymph node metastases (p < 0.01). In addition, patients with invasive tumors had local and distant disease more frequently. The percentage of males who had persistent disease and/or local recurrence was significantly higher than the percentage of males who did not (p < 0.05). Similar results were observed for distant disease (p < 0.01). Independent predictors of recurrence and persistent disease was the presence of lymph node metastases at diagnosis (risk ratio 11.66) and of distant metastases were the presence of lymph node metastases at diagnosis (risk ratio 17.42) and the presence of vascular invasion (risk ratio 2.41). Fifteen patients died due to MTC during follow-up (17.6 %). Patients who died were more frequently males, and had thyroid capsule invasion, extrathyroidal extension, vascular invasion and metastatic disease. Male sex, tumor size and invasive characteristics of the tumor are negative predictive factors for evolution of MTC.
引用
收藏
页码:445 / 451
页数:7
相关论文
共 50 条
  • [21] Risk factors for medullary thyroid carcinoma: a pooled analysis
    Eva Negri
    Elaine Ron
    Silvia Franceschi
    Carlo La Vecchia
    Susan Preston-Martin
    Laurence Kolonel
    Ruth A. Kleinerman
    Kiyohiko Mabuchi
    Fan Jin
    Gun Wingren
    Arne Hallquist
    Fabio Levi
    Athena Linos
    Joseph F. Fraumeni
    [J]. Cancer Causes & Control, 2002, 13 : 365 - 372
  • [22] Medullary carcinoma of the thyroid: Prognostic factors and treatment recommendations
    Fuchshuber, PR
    Loree, TR
    Hicks, WL
    Cheney, RT
    Shedd, DP
    [J]. ANNALS OF SURGICAL ONCOLOGY, 1998, 5 (01) : 81 - 86
  • [23] Medullary carcinoma of the thyroid: Prognostic factors and treatment recommendations
    Pascal R. Fuchshuber
    Thom R. Loree
    Wesley L. Hicks
    Richard T. Cheney
    Donald P. Shedd
    [J]. Annals of Surgical Oncology, 1998, 5 : 81 - 86
  • [24] Metastatic medullary thyroid carcinoma (MTC): disease course, treatment modalities and factors predisposing for drug resistance
    Saltiki, Katerina
    Simeakis, George
    Karapanou, Olga
    Paschou, Stavroula A.
    Alevizaki, Maria
    [J]. ENDOCRINE, 2023, 80 (03) : 570 - 579
  • [25] Metastatic medullary thyroid carcinoma (MTC): disease course, treatment modalities and factors predisposing for drug resistance
    Katerina Saltiki
    George Simeakis
    Olga Karapanou
    Stavroula A. Paschou
    Maria Alevizaki
    [J]. Endocrine, 2023, 80 : 570 - 579
  • [26] WHEN IS MEDULLARY-THYROID CARCINOMA MEDULLARY-THYROID CARCINOMA
    RICCABONA, G
    LADURNER, D
    SCHMID, K
    [J]. WORLD JOURNAL OF SURGERY, 1986, 10 (05) : 745 - 752
  • [27] Medullary thyroid carcinoma
    Hejna, M
    Brodowicz, T
    Kornek, GV
    [J]. ONKOLOGIE, 1998, 21 (04): : 334 - 337
  • [28] Medullary thyroid carcinoma
    Modigliani, E
    [J]. REVUE DE MEDECINE INTERNE, 1999, 20 (06): : 490 - 503
  • [29] Medullary Thyroid Carcinoma
    Pacini, F.
    Castagna, M. G.
    Cipri, C.
    Schlumberger, M.
    [J]. CLINICAL ONCOLOGY, 2010, 22 (06) : 475 - 485
  • [30] MEDULLARY THYROID CARCINOMA
    Griebeler, Marcio L.
    Gharib, Hossein
    Thompson, Geoffrey B.
    [J]. ENDOCRINE PRACTICE, 2013, 19 (04) : 703 - 711